Make us your home page

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

Biotech company Genzyme to pay $22.3 million in Tampa whistle-blower case

TAMPA — A Massachusetts-based biotechnology company has agreed to pay $22.28 million to resolve allegations brought by whistle-blowers in Tampa and Miami that it marketed an inappropriate use for a surgery medication, U.S. government attorneys said.

Genzyme, a corporation known for its research into drugs for rare genetic diseases, is paying the settlement in a lawsuit over Seprafilm, a material it manufactures for use in the operating room.

According to court documents, Genzyme sales representatives encouraged doctors to use the product in a manner not approved by the U.S. Food and Drug Administration, leading to improper claims for reimbursement from hospitals.

"I think these cases are among the most important that our office handles. Health care fraud is a major problem in our country," said A. Lee Bentley III, acting U.S. Attorney for the Middle District of Florida. "These do serve a very important deterrent effect."

The settlement is the result of a civil suit brought under the federal False Claims Act, a 19th-century law that encourages private citizens to expose fraud by government contractors. Whistle-blowers can file suit on behalf of the government and then share in any financial settlement that results.

The Genzyme action was brought by two company sales representatives in 2009.

The amount of the settlement that will be diverted to the whistle-blowers has not yet been determined. One of the private plaintiffs' attorneys, Barry Cohen of Tampa, said they hope to receive between 23 and 24 percent of the settlement, or about $5.2 million.

"They were pharmaceutical salesmen, and they recognized that this was a potential danger," Cohen said. "They saw other people doing it, and they knew it wasn't right."

Sarah Connors, a spokeswoman for Sanofi, Genzyme's parent company, said that Genzyme cooperated with the government investigation and that the company's sales force no longer markets Seprafilm for the unorthodox procedure that spawned the lawsuit.

"Genzyme did take proactive action to address and prohibit this conduct," she said.

According to court documents, Seprafilm is intended to be applied during open surgery to prevent organs and muscle tissue from sticking together. However, the whistle-blowers and lawyers for the federal government alleged that Genzyme sales representatives taught doctors to use it in less invasive procedures — such as laparoscopic or "keyhole" surgeries — by mixing it into a liquidlike "slurry" that could be injected into the body.

Cohen and Bentley said they were not required to prove in the lawsuit that patients had been harmed, only that this use of the drug was not approved by federal regulators and hence not subject to reimbursement by Medicare and Medicaid.

The hefty Genzyme settlement follows two other large payouts secured in recent years by the U.S. Attorney's Office and the Cohen Law Group, including a $217.5 million settlement from WellCare Health Plans and a $10.17 million settlement from Morton Plant Mease Health Care.

Peter Jamison can be reached at or (813) 226-3337. Follow him on Twitter @petejamison.

Biotech company Genzyme to pay $22.3 million in Tampa whistle-blower case 12/23/13 [Last modified: Monday, December 23, 2013 11:27pm]
Photo reprints | Article reprints

© 2017 Tampa Bay Times


Join the discussion: Click to view comments, add yours

  1. Photo gallery: Florida High School Track & Field State Championships, May 6, 2017


    View a gallery of images from Saturday's Florida High School Track & Field State Championships in Bradenton.

    Jefferson High sprinters Eyekeyle Gardner, 17, left, and Kourtney Lawton, 15, compete in the Girls 2A 4x400 Meter relay during the FHSAA Track & Field Finals held at the IMG Academy in Bradenton, Florida on Saturday, May 6, 2017.
  2. Police: 8 dead in Mississippi shooting, including deputy


    BROOKHAVEN, Miss. — Authorities in Mississippi say a suspect is in custody after eight people were killed in a shooting, including a sheriff's deputy.

  3. Photos: 97X BBQ brings Grouplove, Coin, Milky Chance, more to Vinoy Park in St. Petersburg


    Alternative rock fans got a jump start on Memorial Day partying on Saturday at the annual 97X BBQ, which brought Grouplove, Milky Chance, K. Flay, Coin and more to Vinoy Park in St. Petersburg. Kasamba Kokayi was there snapping photos; click the headline of this post for a slideshow.

    Grouplove performed at the 97X BBQ at Vinoy Park in St. Petersburg on May 27, 2017.
  4. Winner and loser of the week in Florida politics


    Winner of the week 1: 'Liquor wall’ proponents. Gov. Rick Scott’s veto of a bill to allow Walmart, Target and other big box stores to sell liquor was a victory for an array of groups, from smaller merchants and Publix (which has stand-alone booze shops near its stores) to those who feel the hard stuff …

  5. Review / photos: Sunset Music Festival brings Major Lazer, safety upgrades to Raymond James Stadium in Tampa


    Somewhere beyond the barricades and mountainous LED stages of the Sunset Music Festival, there had to be worry. There had to thousands of parents in parking lots and empty kitchens, anxiously distracting their minds, every now and then checking their phones.

    Major Lazer headlined the Sunset Music Festival on May 27, 2017 at Raymond James Stadium in Tampa.